Atlas Trials

Dose Escalation Study of Pazopanib Plus TH-302

Clinical trial NCT01485042 · COMPLETED

Trial details

NCT number
NCT01485042
Sponsor
Herbert Hurwitz, MD
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Solid Tumors
Start date
2011-12-01
Primary completion
2013-02-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.